Back to Search Start Over

LO4 : A phase 2, randomized, placebo-controlled study (IMAGO) of LUM001, a novel inhibitor of the apical sodium-dependent bile acid transporter (ASBT), in paediatric patients with alagille syndrome (ALGS).

LO4 : A phase 2, randomized, placebo-controlled study (IMAGO) of LUM001, a novel inhibitor of the apical sodium-dependent bile acid transporter (ASBT), in paediatric patients with alagille syndrome (ALGS).

Authors :
Baker, A.
Kelly, D.
McClean, P.
Karthikeyan, P.
McKiernan, P.
Dorenbaum, A.
Kamath, B.M.
Shneider, B.
Barbat, S.
Medendorp, S.
Raychaudhuri, A.
Kennedy, C.A.
Thompson, R.J.
Source :
Journal of Hepatology. Apr2015 Supplement 2, Vol. 62, pS259-S259. 1p.
Publication Year :
2015

Details

Language :
English
ISSN :
01688278
Volume :
62
Database :
Academic Search Index
Journal :
Journal of Hepatology
Publication Type :
Academic Journal
Accession number :
103201886
Full Text :
https://doi.org/10.1016/S0168-8278(15)30150-1